|
Acetylsalicyclic acid |
CAS 50-78-2 | ||
CH3COOC6H4COOH |
RTECS VO0700000 | ||
Synonyms & Trade Names o-Acetoxybenzoic acid, 2-Acetoxybenzoic acid, Aspirin |
DOT ID & Guide |
Exposure
|
NIOSH REL: TWA 5 mg/m3 | ||
OSHA PEL†: none | |||
IDLH N.D. See: IDLH INDEX | Conversion |
Physical Description Odorless, colorless to white, crystal-line powder. [aspirin] [Note: Develops the vinegar-like odor of acetic acid on contact with moisture.] |
|||
MW: 180.2 |
BP: 284°F (Decomposes) |
MLT: 275°F |
Sol(77°F): 0.3% |
VP: 0 mmHg (approx) |
IP: NA |
|
Sp.Gr: 1.35 |
Fl.P: NA |
UEL: NA |
LEL: NA |
MEC: 40 g/m3 |
Combustible Powder; explosion hazard if dispersed in air. | |||
Incompatibilities & Reactivities Solutions of alkali hydroxides or carbonates, strong oxidizers, moisture [Note: Slowly hydrolyzes in moist air to salicyclic & acetic acids.] |
Measurement Methods NIOSH 0500 See: NMAM or OSHA Methods |
Personal Protection & Sanitation (See protection) Skin: Prevent skin contact Eyes: Prevent eye contact Wash skin: When contaminated Remove: No recommendation Change: Daily Provide: Eyewash, Quick drench |
First Aid (See procedures) Eye: Irrigate immediately Skin: Soap wash Breathing: Respiratory support Swallow: Medical attention immediately |
Important additional information about respirator selection Respirator Recommendations Not available. |
|
Exposure Routes inhalation, ingestion, skin and/or eye contact | |
Symptoms Irritation eyes, skin, upper respiratory system; increased blood clotting time; nausea, vomiting; liver, kidney injury | |
Target Organs
Cancer Site Eyes, skin, respiratory system, blood, liver, kidneys |
See also: INTRODUCTION See ICSC CARD: 0822 |